COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE

The invention relates to antibody polypeptides that monovalently bind CD40L. Antibody polypeptides that are monovalent for binding of CD40L can inhibit CD40L activity while avoiding potential undesirable effects that can occur with antibodies capable of divalent or multivalent binding of CD40L. In o...

Full description

Saved in:
Bibliographic Details
Main Authors LIU HAIQUN, GRANT STEVEN, MOULDER KEVIN
Format Patent
LanguageEnglish
Published 07.06.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to antibody polypeptides that monovalently bind CD40L. Antibody polypeptides that are monovalent for binding of CD40L can inhibit CD40L activity while avoiding potential undesirable effects that can occur with antibodies capable of divalent or multivalent binding of CD40L. In one aspect, a monovalent anti-CD40L antibody polypeptide consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD40L, preferably without substantially agonizing CD40 and/or CD40L activity. In another aspect, the monovalent anti-CD40L antibody polypeptide is a human antibody polypeptide. The invention further encompasses methods of antagonizing CD40/CD40L interactions in an individual and methods of treating diseases or disorders involving CD40/CD40L interactions, the methods involving administering a monovalent anti-CD40L antibody polypeptide to the individual.
AbstractList The invention relates to antibody polypeptides that monovalently bind CD40L. Antibody polypeptides that are monovalent for binding of CD40L can inhibit CD40L activity while avoiding potential undesirable effects that can occur with antibodies capable of divalent or multivalent binding of CD40L. In one aspect, a monovalent anti-CD40L antibody polypeptide consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD40L, preferably without substantially agonizing CD40 and/or CD40L activity. In another aspect, the monovalent anti-CD40L antibody polypeptide is a human antibody polypeptide. The invention further encompasses methods of antagonizing CD40/CD40L interactions in an individual and methods of treating diseases or disorders involving CD40/CD40L interactions, the methods involving administering a monovalent anti-CD40L antibody polypeptide to the individual.
Author MOULDER KEVIN
GRANT STEVEN
LIU HAIQUN
Author_xml – fullname: LIU HAIQUN
– fullname: GRANT STEVEN
– fullname: MOULDER KEVIN
BookMark eNrjYmDJy89L5WSwcfb3DfAP9gzx9PcLVvD19_MPc_Rx9QtRcPMPUnB2MTHwUXDy9HPx9HNXcPRzUfB1DfHwdwlW8HdTCA125WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgYG5gYGpuaWpsaOxsSpAgCsjiv1
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20070057953A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20070057953A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:24 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20070057953A3
Notes Application Number: KR20077008642
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070607&DB=EPODOC&CC=KR&NR=20070057953A
ParticipantIDs epo_espacenet_KR20070057953A
PublicationCentury 2000
PublicationDate 20070607
PublicationDateYYYYMMDD 2007-06-07
PublicationDate_xml – month: 06
  year: 2007
  text: 20070607
  day: 07
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies DOMANTIS LIMITED
RelatedCompanies_xml – name: DOMANTIS LIMITED
Score 2.6800401
Snippet The invention relates to antibody polypeptides that monovalently bind CD40L. Antibody polypeptides that are monovalent for binding of CD40L can inhibit CD40L...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070607&DB=EPODOC&locale=&CC=KR&NR=20070057953A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzJ1SkDpW7Gs7bqCRdaktXNrM9pu7G00awuCdMNV_PdN6qp72lvIwXEJ3GfudwF41JjZ01jSl5naTWVuJXO5b4pCvsmWeW7ymD0V9Q4_6HlT7W2uzxvwUWNhqjmh39VwRK5RS67vZWWv1_9FLFL1Vm6e2DvfWr24sUWkOjsWs2AMidiWM6GEYgljaxRKQfhLE8BLXR0cwKEIpMWkfWdmC1zKetepuGdwNOH8ivIcGlnRghNc_73WgmN_--TNl1vt21zAM6b-hEbDCvmLuDGks8HYCWLEMzmEiaaMkT0MyDB4RYOAIN-JPUoiRF00jZxLeHCdGHsyF2Pxd-rFKNyVWb2CZrEqsjYgNWV5lhui2SnRePRmpks90RWmZoludFl6DZ19nG72k2_htG6JU4wONMvPr-yO-92S3VfX9QNM-IAu
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTmXq1IDSt-JY23UFh2xJa-vaZGzd2Nto1hYE6Yar-O-bxlX3tLeQg-MSuI_f5e4C8Khzq6PzqKtyrR2rwkqmatcqEvkWX6apJWL2uMh3BLTjTvW3uTGvwEfZCyPnhH7L4YhCo5ZC33Npr9f_SSwiays3T_xdbK1enLBHlBIdF7NgTIUMevaIEYYVjHvDsULHv7Si8dLQ-gdwaApQKMHSbFD0pax3nYpzCkcjwS_Lz6CSZHWo4fLvtTocB9snb7Hcat_mHJ4xC0Zs4snOXySMIZv1fZuGSCA5hIne8tHAo8Sjr6hPCQrs0GVkgpiDphP7Ah4cO8SuKsRY_J16MRzvyqxdQjVbZUkDkBbzNEnNotgp0kX0ZsVLIzJaXEsiw2zz-Aqa-zhd7yffQ80NA3_he3R4AydleVzLbEI1__xKboUPzvmdvLofcA6DGA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOSITIONS+MONOVALENT+FOR+CD40L+BINDING+AND+METHODS+OF+USE&rft.inventor=LIU+HAIQUN&rft.inventor=GRANT+STEVEN&rft.inventor=MOULDER+KEVIN&rft.date=2007-06-07&rft.externalDBID=A&rft.externalDocID=KR20070057953A